Schjødt has assisted Vaccibody on the transaction. Vaccibody entered into worldwide license and collaboration agreement with Genentech, a member of the Roche Group, to develop individualized neoantigen…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
